Table 1.
Characteristics of the head and neck cancer patients who participated in this study
| No of patients | 12 |
|---|---|
| Age (years) | 65 (52–89) |
| Gender (M/F) | 9 / 3 |
| Primary tumor state (n) | |
| Pharyngeal cancer | 7 |
| Laryngeal cancer | 1 |
| Lingual cancer | 3 |
| Parotid gland cancer | 1 |
| Metastatic disease (n) | 9 |
| Concomitant radiation therapy (n) | 8 |
| Premedication (n) | |
| Diphenhydramine | 10 |
| Dexamethazone | 12 |
| d‐Chlorpheniramine | 2 |
| Celecoxib | 1 |
| Famotidine | 2 |
| History of tumor surgery (n) | 5 |
| Development of cetuximab‐induced allergic reactiona (n) | 4 (Grade 3: 2, Grade 1: 2) |
a
The severity of allergic reaction was evaluated according to the National Cancer Institute Common Terminology Criteria for Adverse Events version 4.0.